Marliere J[au] - Search Results

Year	Number of Results
1953	1
1956	1
1958	1
1963	2
2001	1
2002	1
2005	1
2006	2
2007	2
2008	3
2009	2
2010	2
2011	1
2012	1
2013	2
2014	1
2024	0

1

Impact of a polymorphism in the IL-12p40 gene on the outcome of kidney transplantation.

Hoffmann TW, Halimi JM, Büchler M, Velge-Roussel F, Al-Najjar A, Marliere JF, Lebranchu Y, Baron C. Hoffmann TW, et al. Among authors: marliere jf. Transplant Proc. 2009 Mar;41(2):654-6. doi: 10.1016/j.transproceed.2008.12.002. Transplant Proc. 2009. PMID: 19328947

2

Association between a polymorphism in the IL-12p40 gene and cytomegalovirus reactivation after kidney transplantation.

Hoffmann TW, Halimi JM, Büchler M, Velge-Roussel F, Goudeau A, Al Najjar A, Boulanger MD, Houssaini TS, Marliere JF, Lebranchu Y, Baron C. Hoffmann TW, et al. Among authors: marliere jf. Transplantation. 2008 May 27;85(10):1406-11. doi: 10.1097/TP.0b013e31816c7dc7. Transplantation. 2008. PMID: 18497679

3

Risk factors for impaired CD4+ T-cell reconstitution following rabbit antithymocyte globulin treatment in kidney transplantation.

Longuet H, Sautenet B, Gatault P, Thibault G, Barbet C, Marliere JF, Halimi JM, Lebranchu Y, Baron C, Büchler M. Longuet H, et al. Among authors: marliere jf. Transpl Int. 2014 Mar;27(3):271-9. doi: 10.1111/tri.12249. Epub 2013 Dec 27. Transpl Int. 2014. PMID: 24279588 Free PMC article.

4

Microalbuminuria in hypertensive nonproteinuric renal transplant recipients: influence of previous acute rejection episodes and sodium intake.

Halimi JM, Al-Najjar A, Buchler M, Giraudeau B, Etienne I, Picou S, Marlière J, Nivet H, Bruyère F, Autret-Leca E, Lebranchu Y. Halimi JM, et al. Among authors: marliere j. Transplant Proc. 2002 May;34(3):801-2. doi: 10.1016/s0041-1345(01)02915-3. Transplant Proc. 2002. PMID: 12034187 No abstract available.

5

Renal resistive index as a new independent risk factor for new-onset diabetes mellitus after kidney transplantation.

Mutinelli-Szymanski P, Caille A, Tranquart F, Al-Najjar A, Büchler M, Barbet C, Marlière JF, Gatault P, Réault J, Boin C, Chatelet V, Laouad I, Nivet H, Lebranchu Y, Halimi JM. Mutinelli-Szymanski P, et al. Among authors: marliere jf. Transpl Int. 2012 Apr;25(4):464-70. doi: 10.1111/j.1432-2277.2012.01445.x. Epub 2012 Feb 24. Transpl Int. 2012. PMID: 22364312 Free article.

6

Autosomal dominant polycystic kidney disease: risk factor for nonmelanoma skin cancer following kidney transplantation.

Bretagnol A, Halimi JM, Roland M, Barbet C, Machet L, Al Najjar A, Marlière JF, Badin J, Nivet H, Lebranchu Y, Büchler M. Bretagnol A, et al. Among authors: marliere jf. Transpl Int. 2010 Sep;23(9):878-86. doi: 10.1111/j.1432-2277.2010.01070.x. Epub 2010 Mar 5. Transpl Int. 2010. PMID: 20230542 Free article.

7

Long-term results of monoclonal anti-Il2-receptor antibody versus polyclonal antilymphocyte antibodies as induction therapy in renal transplantation.

Al Najjar A, Etienne I, Le Pogamp P, Bridoux F, Le Meur Y, Toupance O, Mousson C, Caillard S, Hurault de Ligny B, Marlière JF, Lebranchu Y. Al Najjar A, et al. Among authors: marliere jf. Transplant Proc. 2006 Sep;38(7):2298-9. doi: 10.1016/j.transproceed.2006.06.133. Transplant Proc. 2006. PMID: 16980070

8

Association between a polymorphism in the human programmed death-1 (PD-1) gene and cytomegalovirus infection after kidney transplantation.

Hoffmann TW, Halimi JM, Büchler M, Velge-Roussel F, Goudeau A, Al-Najjar A, Marliere JF, Lebranchu Y, Baron C. Hoffmann TW, et al. Among authors: marliere jf. J Med Genet. 2010 Jan;47(1):54-8. doi: 10.1136/jmg.2009.068841. Epub 2009 Jul 5. J Med Genet. 2010. PMID: 19581275

9

Immunosuppressive medications, clinical and metabolic parameters in new-onset diabetes mellitus after kidney transplantation.

Roland M, Gatault P, Doute C, Büchler M, Al-Najjar A, Barbet C, Chatelet V, Marlière JF, Nivet H, Lebranchu Y, Halimi JM. Roland M, et al. Among authors: marliere jf. Transpl Int. 2008 Jun;21(6):523-30. doi: 10.1111/j.1432-2277.2008.00640.x. Epub 2008 Feb 4. Transpl Int. 2008. PMID: 18266773 Free article.

10

Doubling of serum creatinine in clinical trials, cost-effectiveness studies, and individual patients: adequate use in renal transplantation.

Gatault P, Al-Najjar A, Barbet C, Roland M, Laouad I, Buchler M, Marlière JF, Métais PE, Clément A, Nivet H, Lebranchu Y, Halimi JM. Gatault P, et al. Among authors: marliere jf. Transplantation. 2011 Nov 15;92(9):1012-7. doi: 10.1097/TP.0b013e31823015e4. Transplantation. 2011. PMID: 21941225

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

22 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year